NCT04723290

COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

SARS-CoV-2 Seroconversion Study Among GHdC Staff Members

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 2,817 (actual)
• Sponsor: Grand Hôpital de Charleroi · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The management of the Grand Hôpital de Charleroi hospital authorized the performance of a serology for each member of the establishment's staff in order to better characterize the proportion of its employees who have already been in contact with the SARS CoV-2 virus for organizational and evaluation purposes symptoms.

Detailed description

At the start of the SARS-CoV-2 pandemic, several workers had symptoms compatible with COVID-19 at a time when PCR (smear) testing was only allowed for hospitalized people. In addition, the PCR test has a fairly low sensitivity. In this context, serology can make it possible to determine whether the symptoms are indeed linked to exposure to SARS-CoV-2. As a hospital, and in order to prepare for a possible second epidemic wave, it is also useful to know the proportion of staff members who have already been in contact with the virus for organizational purposes and symptom assessment. .

Conditions

• Covid19

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Serological tests for SARS Cov-2	Each participant will have a blood test on a dry tube of maximum 8 ml of whole blood

Timeline

• Start date: 2020-06-20
• Primary completion: 2020-10-31
• Completion: 2020-12-31
• First posted: 2021-01-25
• Last updated: 2021-03-25

Locations

1 site across 1 country: Belgium